SIMCERE PHARMAC. GRP LTD (S2P) — Financial Flexibility Index
SIMCERE PHARMAC. GRP LTD (S2P) has a Financial Flexibility Index of 0.54x as of December 2025. Free cash flow of €2.88 Billion (operating CF €2.01 Billion minus capex €862.20 Million) represents 1% of total liabilities (€5.31 Billion). Check cash flow reinvestment rate of SIMCERE PHARMAC. GRP LTD to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SIMCERE PHARMAC. GRP LTD Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for SIMCERE PHARMAC. GRP LTD across 5 annual periods. For the full cash flow conversion analysis, see cash flow conversion of SIMCERE PHARMAC. GRP LTD.
Annual Financial Flexibility Index for SIMCERE PHARMAC. GRP LTD (2021–2025)
Year-by-year free cash flow to debt coverage for SIMCERE PHARMAC. GRP LTD. Explore cash flow to debt ratio of SIMCERE PHARMAC. GRP LTD to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | €2.88 Billion | €2.01 Billion | €5.31 Billion | ▲ +11.7% |
| 2024 | 0.48x | €2.15 Billion | €1.39 Billion | €4.44 Billion | ▲ +55.7% |
| 2023 | 0.31x | €1.13 Billion | €151.05 Million | €3.63 Billion | ▼ -44.2% |
| 2022 | 0.56x | €2.03 Billion | €1.35 Billion | €3.64 Billion | ▲ +27354.5% |
| 2021 | 0.00x | €7.52 Million | €-201.97 Million | €3.70 Billion | — |